Core Laboratories Nv Stock Analysis

CLB Stock  USD 16.97  0.21  1.22%   
Core Laboratories NV is undervalued with Real Value of 19.87 and Target Price of 23.25. The main objective of Core Laboratories stock analysis is to determine its intrinsic value, which is an estimate of what Core Laboratories NV is worth, separate from its market price. There are two main types of Core Laboratories' stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Core Laboratories' performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Core Laboratories' stock to identify patterns and trends that may indicate its future price movements.
The Core Laboratories stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Core Laboratories is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Core Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Core Laboratories' ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Core Stock Analysis Notes

About 99.0% of the company shares are held by institutions such as insurance companies. The book value of Core Laboratories was currently reported as 4.8. The company has Price/Earnings To Growth (PEG) ratio of 2.15. Core Laboratories last dividend was issued on the 9th of February 2024. The entity had 2:1 split on the 9th of July 2010. Core Laboratories N.V. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, Canada, and internationally. The company was founded in 1936 and is based in Amstelveen, the Netherlands. Core Laboratories is traded on New York Stock Exchange in the United States. For more info on Core Laboratories NV please contact Lawrence Bruno at 713 328 2673 or go to https://www.corelab.com.

Core Laboratories Quarterly Total Revenue

128.21 Million

Core Laboratories Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Core Laboratories' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Core Laboratories NV or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Core Laboratories is unlikely to experience financial distress in the next 2 years
Core Laboratories has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are held by institutions such as insurance companies
On 4th of March 2024 Core Laboratories paid $ 0.01 per share dividend to its current shareholders
Latest headline from finance.yahoo.com: What Makes Core Laboratories a New Strong Buy Stock

Core Laboratories Upcoming and Recent Events

Earnings reports are used by Core Laboratories to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Core Laboratories previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
31st of January 2024
Upcoming Quarterly Report
View
24th of April 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
31st of January 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Core Largest EPS Surprises

Earnings surprises can significantly impact Core Laboratories' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2022-04-27
2022-03-310.090.08-0.0111 
2003-05-09
2003-03-310.050.04-0.0120 
2002-05-07
2002-03-310.060.05-0.0116 
View All Earnings Estimates

Core Laboratories Thematic Classifications

In addition to having Core Laboratories stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Petroleum and Natural Gas Idea
Petroleum and Natural Gas
USA Equities from Petroleum and Natural Gas industry as classified by Fama & French

Core Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Core Laboratories is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Core Laboratories NV backward and forwards among themselves. Core Laboratories' institutional investor refers to the entity that pools money to purchase Core Laboratories' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Royce & Associates, Lp2023-12-31
914.3 K
Fisher Asset Management, Llc2023-12-31
754.4 K
Disciplined Growth Investors Inc2023-12-31
752.4 K
Morgan Stanley - Brokerage Accounts2023-12-31
727.5 K
Van Eck Associates Corporation2023-12-31
586.4 K
Charles Schwab Investment Management Inc2023-12-31
580.4 K
Northern Trust Corp2023-12-31
494.3 K
Bank Of New York Mellon Corp2023-12-31
464 K
Amvescap Plc.2023-12-31
412.5 K
Ariel Investments, Llc2023-12-31
M
Blackrock Inc2023-12-31
M
Note, although Core Laboratories' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Core Market Capitalization

The company currently falls under 'Small-Cap' category with a total capitalization of 801.69 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Core Laboratories's market, we take the total number of its shares issued and multiply it by Core Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Core Profitablity

Core Laboratories' profitability indicators refer to fundamental financial ratios that showcase Core Laboratories' ability to generate income relative to its revenue or operating costs. If, let's say, Core Laboratories is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Core Laboratories' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Core Laboratories' profitability requires more research than a typical breakdown of Core Laboratories' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of 0.07 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.13 %, which entails that for every 100 dollars of revenue, it generated $0.13 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.08  0.15 
Return On Capital Employed 0.11  0.21 
Return On Assets 0.06  0.10 
Return On Equity 0.16  0.32 

Management Efficiency

Core Laboratories has Return on Asset of 0.0605 % which means that on every $100 spent on assets, it made $0.0605 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1768 %, implying that it generated $0.1768 on every 100 dollars invested. Core Laboratories' management efficiency ratios could be used to measure how well Core Laboratories manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Tangible Assets is expected to grow to 0.15. The current year's Return On Capital Employed is expected to grow to 0.21. At present, Core Laboratories' Non Currrent Assets Other are projected to decrease significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 26 M, whereas Total Assets are forecasted to decline to about 550.2 M.
Last ReportedProjected for Next Year
Book Value Per Share 4.82  2.62 
Net Current Asset Value 0.00  0.00 
Tangible Asset Value 0.00  0.00 
Tangible Book Value Per Share 2.64  2.78 
Enterprise Value Over EBITDA 14.73  14.28 
Price Book Value Ratio 3.67  6.42 
Enterprise Value Multiple 14.73  14.28 
Price Fair Value 3.67  6.42 
Enterprise Value4.5 B2.7 B
The analysis of Core Laboratories' management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Core Laboratories' future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Core Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Dividend Yield
0.0023
Forward Dividend Yield
0.0023
Forward Dividend Rate
0.04
Beta
2.426

Technical Drivers

As of the 23rd of April, Core Laboratories shows the Mean Deviation of 1.72, risk adjusted performance of 0.0642, and Downside Deviation of 2.3. Core Laboratories technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We were able to break down and interpolate nineteen technical drivers for Core Laboratories NV, which can be compared to its peers. Please confirm Core Laboratories value at risk, expected short fall, and the relationship between the treynor ratio and downside variance to decide if Core Laboratories is priced correctly, providing market reflects its regular price of 16.97 per share. Given that Core Laboratories has jensen alpha of 0.1142, we suggest you to validate Core Laboratories NV's prevailing market performance to make sure the company can sustain itself at a future point.

Core Laboratories Price Movement Analysis

Execute Study
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Core Laboratories middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Core Laboratories. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Core Laboratories Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Core Laboratories insiders, such as employees or executives, is commonly permitted as long as it does not rely on Core Laboratories' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Core Laboratories insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Core Laboratories Predictive Daily Indicators

Core Laboratories intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Core Laboratories stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Core Laboratories Corporate Filings

Core Laboratories Forecast Models

Core Laboratories' time-series forecasting models are one of many Core Laboratories' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Core Laboratories' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Core Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Core Laboratories prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Core shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Core Laboratories. By using and applying Core Stock analysis, traders can create a robust methodology for identifying Core entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.08  0.11 
Operating Profit Margin 0.11  0.14 
Net Profit Margin 0.07  0.08 
Gross Profit Margin 0.18  0.20 

Current Core Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Core analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Core analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
23.25Hold9Odds
Core Laboratories NV current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Core analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Core stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Core Laboratories, talking to its executives and customers, or listening to Core conference calls.
Core Analyst Advice Details

Core Stock Analysis Indicators

Core Laboratories NV stock analysis indicators help investors evaluate how Core Laboratories stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Core Laboratories shares will generate the highest return on investment. By understating and applying Core Laboratories stock analysis, traders can identify Core Laboratories position entry and exit signals to maximize returns.
Begin Period Cash Flow15.4 M
Common Stock Shares Outstanding47.5 M
Total Stockholder Equity224.8 M
Quarterly Earnings Growth Y O Y-0.724
Property Plant And Equipment Net153.5 M
Cash And Short Term Investments15.1 M
Cash15.1 M
Accounts Payable33.5 M
Net Debt200.3 M
50 Day M A16.0616
Total Current Liabilities88.1 M
Other Operating Expenses456 M
Non Current Assets Total363.3 M
Forward Price Earnings26.5252
Non Currrent Assets Other36.3 M
Stock Based Compensation-60 M
When determining whether Core Laboratories offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Core Laboratories' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Core Laboratories Nv Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Core Laboratories Nv Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Core Laboratories NV. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Complementary Tools for Core Stock analysis

When running Core Laboratories' price analysis, check to measure Core Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Core Laboratories is operating at the current time. Most of Core Laboratories' value examination focuses on studying past and present price action to predict the probability of Core Laboratories' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Core Laboratories' price. Additionally, you may evaluate how the addition of Core Laboratories to your portfolios can decrease your overall portfolio volatility.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Is Core Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Core Laboratories. If investors know Core will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Core Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.72)
Dividend Share
0.04
Earnings Share
0.51
Revenue Per Share
10.92
Quarterly Revenue Growth
0.005
The market value of Core Laboratories is measured differently than its book value, which is the value of Core that is recorded on the company's balance sheet. Investors also form their own opinion of Core Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Core Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Core Laboratories' market value can be influenced by many factors that don't directly affect Core Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Core Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine if Core Laboratories is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Core Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.